Birdwatch Note Rating
2023-03-16 19:11:31 UTC - HELPFUL
Rated by Participant: A31423042CF8811819D879E44B9FECA0169B27DB1157434345F14E05483B6FEF
Participant Details
Original Note:
From a GAO report on mifepristone: "FDA approved the drug under a provision of the agency’s Subpart H regulations … titled “Accelerated Approval of New Drugs". The regulation "provides FDA with flexibilities that allow the agency to accelerate the approval process" https://www.gao.gov/assets/gao-08-751.pdf
All Note Details